Propranolol for Akathisia Treatment
Propranolol is the first-line pharmacological treatment for antipsychotic-induced akathisia, with doses of 10-30 mg two to three times daily being effective in most cases. 1
Understanding Akathisia
Akathisia is characterized by a distressing sense of inner restlessness and inability to remain still, often manifesting as:
- Constant pacing or physical agitation
- Subjective feelings of restlessness
- Inability to sit still or remain in one position
It is commonly misinterpreted as psychotic agitation, anxiety, or worsening of psychiatric symptoms, making it a frequent reason for medication non-adherence.
Evidence for Propranolol in Akathisia
Mechanism and Efficacy
- Propranolol, a non-selective beta-adrenergic receptor antagonist, has consistently demonstrated effectiveness in treating akathisia
- Response is typically rapid, often occurring within 24 hours 2
- Complete remission can be achieved in approximately 64% of cases 2
- Effective at relatively low doses (30-80 mg/day) 2
Dosing Recommendations
- Starting dose: 10 mg two to three times daily
- Can be titrated up to 30 mg three times daily if needed
- Lower doses may be considered in patients with cardiovascular concerns
Clinical Guidelines Support
The 2025 INTEGRATE guidelines specifically recommend propranolol for akathisia management:
- "Akathisia can potentially be managed with dose reduction. A switch to quetiapine or olanzapine can also be considered. Alternatively, adjunctive propranolol may be an option (10 mg or up to 30 mg, two to three times daily)." 1
The American Academy of Child and Adolescent Psychiatry also recognizes akathisia as a common extrapyramidal side effect of antipsychotics and notes that it "is often misinterpreted as psychotic agitation or anxiety and is a common reason for medication noncompliance." They further state that "relief has been reported with β-blockers and benzodiazepines." 1
Alternative Options When Propranolol Is Contraindicated
If propranolol is contraindicated (e.g., asthma, bradycardia, heart block):
- Anticholinergic agents may provide symptomatic relief 3
- Benzodiazepines can be considered as alternatives 1
- Serotonin 5-HT2a receptor antagonists (particularly mirtazapine 7.5-15 mg daily) have emerging evidence 3
- Vitamin B6 (300-600 mg twice daily) has shown comparable efficacy to propranolol in a small trial 4
Important Clinical Considerations
- Akathisia is often confused with anxiety or agitation, leading to inappropriate management
- Propranolol's side effects include orthostatic hypotension and bradycardia 3
- Contraindications include asthma, heart block greater than first degree, and cardiogenic shock
- Monitor for cardiovascular effects, especially in patients with pre-existing cardiac conditions
- Propranolol has also shown efficacy in tardive akathisia, a variant that can persist even after antipsychotic discontinuation 5
Treatment Algorithm
- First-line: Propranolol 10-30 mg two to three times daily
- If ineffective or contraindicated:
- Consider dose reduction of the causative antipsychotic
- Switch to an antipsychotic with lower risk of akathisia (quetiapine or olanzapine)
- Try mirtazapine 7.5-15 mg daily
- Consider vitamin B6 300-600 mg twice daily
- For persistent cases:
- Combination therapy may be necessary
- Benzodiazepines can provide symptomatic relief
Propranolol remains the most evidence-based treatment for akathisia, with a favorable side effect profile at the doses typically used for this indication.